Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.

Journal article

de Heer EC. et al, (2023), J Exp Clin Cancer Res, 42

p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer

Journal article

Miller P. et al, (2023), Cell Death & Differentiation

Oxali(IV)Fluors: Fluorescence Responsive Oxaliplatin(IV) Complexes Identify a Hypoxia-Dependent Reduction in Can-cer Cells

Journal article

Boulet M. et al, (2023), Journal of the American Chemical Society

A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment

Journal article

Pelizzari-Raymundo D. et al, (2023), iScience, 26

Load More